"Noncognitive" symptoms of early Alzheimer disease A longitudinal analysis

被引:141
|
作者
Masters, Mary Clare [6 ]
Morris, John C. [1 ,2 ,3 ,4 ,5 ,6 ]
Roe, Catherine M. [1 ,5 ,6 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
[3] Washington Univ, Sch Med, Dept Phys Therapy, St Louis, MO USA
[4] Washington Univ, Sch Med, Dept Occupat Therapy, St Louis, MO USA
[5] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, St Louis, MO USA
[6] Washington Univ, Sch Med, St Louis, MO 63110 USA
关键词
NON-COGNITIVE SYMPTOMS; DATA SET UDS; PSYCHOLOGICAL SYMPTOMS; CSF BIOMARKERS; DEPRESSION; DEMENTIA; PREVALENCE; PLAQUES; CENTERS; TANGLES;
D O I
10.1212/WNL.0000000000001238
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives:To observe the natural time course of noncognitive symptoms before the onset of symptomatic Alzheimer disease dementia.Methods:Using the National Alzheimer's Coordinating Center Uniform Data Set from September 2005 to March 2013, data from cognitively normal individuals who were aged 50 years or older at first visit and had subsequent follow-up were analyzed. Survival analyses were used to examine the development of particular symptoms relative to each other on the Neuropsychiatric Inventory Questionnaire (NPI-Q), Functional Activities Questionnaire, and Geriatric Depression Scale, and to compare the development of individual symptoms for persons who did and did not receive a Clinical Dementia Rating (CDR) >0 (indicating abnormal cognition) during the follow-up period.Results:The order of symptom occurrence on the NPI-Q was similar for participants who remained at CDR 0 and for those who received a CDR >0 over the follow-up period, although the time to most NPI-Q symptoms was faster for participants who received a CDR >0 (p < 0.001). With the exception of memory, Geriatric Depression Scale symptoms reported by both CDR groups were similar.Conclusions:We found a significantly earlier presence of positive symptoms on the NPI-Q in cognitively normal patients who subsequently developed CDR >0. Among participants with no depression symptoms at baseline, results suggest that depressive symptoms may increase with aging regardless of incipient dementia. Such findings begin to delineate the noncognitive course of Alzheimer disease dementia in the preclinical stages. Future research must further elucidate the correlation between noncognitive changes and distinct dementia subtypes.
引用
收藏
页码:617 / 622
页数:6
相关论文
共 50 条
  • [1] Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease
    Frisoni, GB
    Geroldi, C
    ARCHIVES OF NEUROLOGY, 2001, 58 (11) : 1939 - 1940
  • [2] Noncognitive disturbances in Alzheimer's disease: Frequency, longitudinal course, and relationship to cognitive symptoms
    Marin, DB
    Green, CR
    Schmeidler, J
    Harvey, PD
    Lawlor, BA
    Ryan, TM
    Aryan, M
    Davis, KL
    Mohs, RC
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (11) : 1331 - 1338
  • [4] Noncognitive symptoms in Alzheimer disease and caregivers distress in Chile
    Rohde, G
    Quiroga, P
    Fasce, M
    Fasce, F
    BRAIN AND COGNITION, 2002, 49 (02) : 253 - 255
  • [5] Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease
    Levy, ML
    Cummings, JL
    Fairbanks, LA
    Sultzer, DL
    Small, GW
    BIOLOGICAL PSYCHIATRY, 1999, 45 (04) : 422 - 425
  • [6] Specificity of symptoms of depression in Alzheimer disease - A longitudinal analysis
    Starkstein, SE
    Mizrahi, R
    Garau, L
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (09): : 802 - 807
  • [7] Specificity of symptoms of depression in Alzheimer disease: A longitudinal analysis
    Hasche, Leslie
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 14 (08): : 716 - 717
  • [8] Noncognitive symptoms and long-term treatment expectations for Alzheimer disease
    Blesa, R
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 : S9 - S16
  • [9] The Alzheimer's disease assessment scale .6. Noncognitive signs and symptoms in outpatients with Alzheimer's disease
    Doraiswamy, PM
    Bieber, F
    Kaiser, L
    Gulanski, B
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 514 - 514
  • [10] Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data
    Ozawa, Chisa
    Roberts, Rachel
    Yoshida, Kazunari
    Suzuki, Takefumi
    Lebowitz, Barry
    Reeves, Suzanne
    Howard, Robert
    Abe, Takayuki
    Mimura, Masaru
    Uchida, Hiroyuki
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (09) : E1204 - +